Environmental Remediation System utilizing Fusion Protein Technology

Publication ID: 24-11857601_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Environmental Remediation System utilizing Fusion Protein Technology,” Published Technical Disclosure No. 24-11857601_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857601_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,601.

Summary of the Inventive Concept

The inventive concept leverages the core fusion protein technology from the original patent to develop novel systems and methods for monitoring and controlling environmental pollution in various settings, including industrial, indoor, water, soil, and agricultural environments.

Background and Problem Solved

The original patent focused on pharmaceutical compositions for cancer treatment, but the fusion protein technology has untapped potential for addressing environmental pollution. Current environmental monitoring and remediation methods are often inadequate, inefficient, or costly. The new inventive concept addresses these limitations by applying the fusion protein technology to develop innovative solutions for environmental pollution control.

Detailed Description of the Inventive Concept

The inventive concept encompasses a range of systems and methods that integrate the fusion protein dimer comprising a CD80 protein or fragment and an IL-2 protein or variant. These systems include air quality monitoring and control systems, indoor air pollution reduction methods, water pollution detection and removal devices, soil pollution monitoring systems, and agricultural pollution reduction methods. The fusion protein technology enables the development of highly sensitive and selective sensors, efficient air and water purification agents, and targeted pollutant removal mechanisms.

Novelty and Inventive Step

The new claims introduce a paradigm shift by applying the fusion protein technology to environmental pollution control, which is unrelated to the original patent's cancer treatment focus. The inventive concept's novelty lies in the unexpected application of the fusion protein technology to develop innovative solutions for environmental remediation.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different protein fragments, variants, or combinations to target specific pollutants or environmental settings. Variations could also involve integrating the fusion protein technology with existing environmental monitoring and remediation systems to enhance their effectiveness.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the environmental remediation industry, with potential applications in industrial settings, residential areas, agricultural sectors, and water treatment facilities. The market for environmental pollution control is substantial, and the inventive concept's innovative solutions could capture a significant share of this market.

CPC Classifications

SectionClassGroup
A A61 A61K38/2013
A A61 A61K31/337
A A61 A61K31/444
A A61 A61K31/4439
A A61 A61K31/47
A A61 A61K31/4709
A A61 A61K31/502
A A61 A61K31/506
A A61 A61K31/5025
A A61 A61K31/519
A A61 A61K31/708
A A61 A61K33/243
A A61 A61K38/1774
A A61 A61K39/3955
A A61 A61K45/06
A A61 A61P35/00

Field of Art

Biotechnology and pharmaceutical engineering, with expertise in protein engineering, fusion protein design, and therapeutic/diagnostic applications across biological systems

Person of Ordinary Skill (PHOSITA) Profile

A researcher or engineer with advanced degrees in molecular biology or bioengineering, experienced in protein modification techniques, understanding of protein-protein interactions, and ability to adapt protein technologies across different domains

Obviousness Rationale

A PHOSITA would recognize that the fusion protein technology disclosed in the source patent represents a versatile platform with potential applications beyond cancer treatment. The core structural elements of the CD80 fragment and IL-2 variant demonstrate adaptable binding and signaling capabilities that could be predictably extended to environmental monitoring and remediation technologies.

Obvious Combinations & Variations

Source Patent Element
Fusion protein dimer with CD80 fragment and IL-2 variant
PTD Variation
Applying fusion protein structure to environmental sensor and pollution detection systems
Obviousness Reasoning
Known protein engineering techniques allow predictable repurposing of protein structures for sensing and interaction applications, representing a standard design approach in biotechnology
Source Patent Element
Pharmaceutical composition with specific protein configuration
PTD Variation
Adapting protein configuration for air, water, and soil pollution monitoring devices
Obviousness Reasoning
A PHOSITA would recognize that protein-based sensing mechanisms are transferable across biological and environmental domains using standard protein modification techniques
Source Patent Element
Targeted protein interaction mechanism from cancer treatment context
PTD Variation
Extending protein interaction principles to pollutant binding and removal strategies
Obviousness Reasoning
Protein-based targeting mechanisms are well-understood as adaptable technologies that can be modified for different binding and interaction requirements
Source Patent Element
Combination of protein dimer with therapeutic/diagnostic agents
PTD Variation
Integrating fusion protein with environmental monitoring and purification agents
Obviousness Reasoning
Interdisciplinary protein engineering approaches commonly involve adapting protein structures across different technological domains using predictable molecular design principles
Source Patent Element
Specific protein fragment configuration from original patent
PTD Variation
Modifying protein fragment configuration for environmental pollution detection
Obviousness Reasoning
Protein fragment reconfiguration represents a standard technique in biotechnology for expanding technological applications using known molecular engineering approaches
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857601, a person having ordinary skill in the art would find the environmental remediation applications disclosed herein to be obvious variations of the original fusion protein technology, representing predictable extensions of known protein engineering principles and demonstrating no inventive step beyond the scope of ordinary technological adaptation.

Original Patent Information

Patent NumberUS 11,857,601
TitlePharmaceutical composition for cancer treatment comprising fusion protein including IL-2 protein and CD80 protein and anticancer drug
Assignee(s)GI Innovation, Inc.